摘要
目的 观察东菱克栓酶加低分子肝素治疗急性脑梗死的疗效及安全性。方法 在东菱克栓酶常规疗程结束后 ,2 8例入选病人加用低分子肝素皮下注射。结果 总有效率达 82 .1 4%,神经功能缺损评分显著进步 ( P <0 .0 5) ;血液流变学多项指标进一步改善 ;而且加用低分子肝素后 PCT、PT、KPTT影响不大 ( P >0 .0 5)。结论 严格入选标准和必要的凝血功能监测 ,加用低分子肝素能在一定程度上提高疗效 ,改善预后 ,临床出血发生率低 ,应用方便。
Objective To study the effects and safes of DF 521 and low molecular weight Heparin in treatment of acute cerebral infarction Methods After routine remedy of DF 521,twenty eight patients with acute cerebral infarction were treated with low molecular weight Heparin Results The effective rate was 82 14%,the damage score of neural function was increased significantly,many marks of hemorrheology were inproved,while levels of PCT,PT and KPTT were not influenced by adding Heparin Conclusions According to the standard of cases of choice and determination of some coagulative factors,DF 521 and low molecular weight Heparin have important values to improve the outcome of the patients It suggested that this method is a safe,effective and convenient therapy of acute cerebral infarction
出处
《蛇志》
2000年第1期15-17,共3页
Journal of Snake
